Browse Drug Recalls

8 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 8 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 8 FDA drug recalls.

Clear
DateProductReasonClassFirm
Sep 7, 2023 Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouche... Subpotent: Out of Specification result observed for low assay Class III SUN PHARMACEUTICAL INDUSTRIES INC
Apr 1, 2022 Cequa (cyclosporine ophthalmic solution) 0.09%, packaged in 6 pouches x 10 si... Subpotent Drug and Presence of Particulate Matter: low out-of-specification results obtained for ... Class III SUN PHARMACEUTICAL INDUSTRIES INC
May 7, 2021 Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouche... Subpotent and Presence of Particulates . Class III SUN PHARMACEUTICAL INDUSTRIES INC
Feb 22, 2021 Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouche... Subpotent Class III SUN PHARMACEUTICAL INDUSTRIES INC
Feb 11, 2016 Alendronate Sodium Tablets, USP, 70 mg*, 4-count blisters per carton, Rx only... Failed Impurities/Degradation Specifications: Observed levels of highest unknown impurity exceedi... Class II Sun Pharma Global Fze
Jul 17, 2015 buPROPion Hydrochloride Extended-¿release Tablets USP (SR), 200 mg, Twice-A-... Failed Dissolution Specification: During analysis of the 18 month long term stability testing, it... Class III Sun Pharma Global Fze
Jan 21, 2015 Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 3 mL bottle, Rx only, Distr... Presence of Particulate Matter: lot is not meeting the specification limit for number of particle... Class II Sun Pharma Global Fze
Jan 21, 2015 Levetiracetam, extended release tablets, 750 mg, 60-count bottle, Rx only, Ma... Failed Dissolution Specifications: 6 month time point. Class II Sun Pharma Global Fze

Frequently Asked Questions

When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.